NH joins 40 states in lawsuit against 6 generic drug makers for price-fixing

The complaint, filed in the U.S. District Court for the District of Connecticut, alleges that with Heritage as the ringleader, the companies regularly colluded to illegal bidding practices for two generic drugs: doxycycline hyclate delayed release, an antibiotic used to treat a range of conditions including respiratory tract infections; and glyburide, an oral diabetes medication. READ MORE